InfuSystem Holdings, Inc.
DE ˙ DB ˙ US45685K1025
7,45 € ↑0,10 (1,36%)
2026-06-04
AKTIENPREIS
SecurityDE:1TZ / InfuSystem Holdings, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership88,408 shares
Latest Disclosed Value $ 816,006
Morgan Stanley reports 32.97% increase in ownership of 1TZ / InfuSystem Holdings, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 88,408 shares of InfuSystem Holdings, Inc. (DE:1TZ) valued at $711,684 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 66,487 shares of InfuSystem Holdings, Inc.. This represents a change in shares of 32.97% during the quarter. The current value of the position is $658,640 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INFUSYSTEM HLDGS COM 45685K102 88,408 21,921 32.97 816 36.91 0.0000
2026-05-27 2025-12-31 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 66,487 22,236 50.25 596 30.13 0.0000
2026-02-13 2025-12-31 13F INFUSYSTEM HLDGS COM 45685K102 66,487 22,236 596 0.0000
2026-05-27 2025-09-30 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 44,251 -30,052 -40.45 458 -1.08 0.0000
2025-11-14 2025-09-30 13F INFUSYSTEM HLDGS COM 45685K102 44,251 -30,052 458 0.0000
2025-08-15 2025-06-30 13F INFUSYSTEM HLDGS COM 45685K102 74,303 -16,576 -18.24 464 -5.12 0.0000
2025-05-15 2025-03-31 13F INFUSYSTEM HLDGS COM 45685K102 90,879 -7,970 -8.06 489 -41.56 0.0000
2025-05-15 2024-12-31 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 98,849 -2,059 -2.04 835 23.52 0.0001
2025-02-14 2024-12-31 13F INFUSYSTEM HLDGS COM 45685K102 98,849 -2,059 835 0.0001
2025-05-14 2024-09-30 13F/A-2 INFUSYSTEM HLDGS COM 45685K102 100,908 32,316 47.11 676 44.44 0.0000
2025-02-14 2024-09-30 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 100,908 32,316 676 0.0000
2024-11-14 2024-09-30 13F INFUSYSTEM HLDGS COM 45685K102 100,908 32,316 676 0.0000
2025-05-14 2024-06-30 13F/A-2 INFUSYSTEM HLDGS COM 45685K102 68,592 38,888 130.92 468 84.25 0.0000
2024-10-17 2024-06-30 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 68,592 38,888 468 0.0000
2024-08-14 2024-06-30 13F INFUSYSTEM HLDGS COM 45685K102 68,592 38,888 468 0.0000
2024-10-17 2024-03-31 13F/A-2 INFUSYSTEM HLDGS COM 45685K102 29,704 -9,954 -25.10 255 -39.09 0.0000
2024-08-16 2024-03-31 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 29,704 -9,954 255 0.0000
2024-05-15 2024-03-31 13F INFUSYSTEM HLDGS COM 45685K102 29,704 -9,954 255 0.0000
2024-08-16 2023-12-31 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 39,658 26,739 206.97 418 236.29 0.0000
2024-02-13 2023-12-31 13F INFUSYSTEM HLDGS COM 45685K102 39,658 26,739 418 0.0000
2023-11-15 2023-09-30 13F INFUSYSTEM HLDGS COM 45685K102 12,919 -4,900 -27.50 125 -27.49 0.0000
2023-08-14 2023-06-30 13F INFUSYSTEM HLDGS COM 45685K102 17,819 -6,350 -26.27 172 -8.56 0.0000
2023-05-15 2023-03-31 13F INFUSYSTEM HLDGS COM 45685K102 24,169 12,967 115.76 187 92.78 0.0000
2023-02-14 2022-12-31 13F INFUSYSTEM HLDGS COM 45685K102 11,202 8,657 340.16 97 438.89 0.0000
2022-11-14 2022-09-30 13F INFUSYSTEM HLDGS COM 45685K102 2,545 -20,698 -89.05 18 -91.96 0.0000
2022-10-27 2022-06-30 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 23,243 16,237 231.76 224 224.64 0.0000
2022-08-15 2022-06-30 13F INFUSYSTEM HLDGS COM 45685K102 23,243 16,237 224 0.0000
2022-10-27 2022-03-31 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 7,006 -6,188 -46.90 69 -69.20 0.0000
2022-05-13 2022-03-31 13F INFUSYSTEM HLDGS COM 45685K102 7,006 -6,188 69 0.0000
2022-02-14 2021-12-31 13F INFUSYSTEM HLDGS COM 45685K102 13,194 -100,394 -88.38 224 -84.85 0.0000
2021-11-15 2021-09-30 13F INFUSYSTEM HLDGS COM 45685K102 113,588 4,494 4.12 1,479 -34.79 0.0002
2021-08-23 2021-06-30 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 109,094 67,950 165.15 2,268 170.97 0.0003
2021-08-16 2021-06-30 13F INFUSYSTEM HLDGS COM 45685K102 109,094 67,950 2,268 0.0001
2021-05-17 2021-03-31 13F INFUSYSTEM HLDGS COM 45685K102 41,144 20,525 99.54 837 116.28 0.0001
2021-02-16 2020-12-31 13F INFUSYSTEM HLDGS COM 45685K102 20,619 9,315 82.40 387 168.75 0.0001
2020-11-13 2020-09-30 13F INFUSYSTEM HLDGS COM 45685K102 11,304 4,583 68.19 144 84.62 0.0000
2020-08-14 2020-06-30 13F INFUSYSTEM HLDGS COM 45685K102 6,721 5,212 345.39 78 500.00 0.0000
2020-05-26 2020-03-31 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 1,509 -492 -24.59 13 -23.53 0.0000
2020-05-15 2020-03-31 13F INFUSYSTEM HLDGS COM 45685K102 1,509 -492 13 0.9987
2020-02-14 2019-12-31 13F INFUSYSTEM HLDGS COM 45685K102 2,001 -260 -11.50 17 41.67 0.0000
2019-11-14 2019-09-30 13F INFUSYSTEM HLDGS COM 45685K102 2,261 381 20.27 12 50.00 0.0000
2019-08-14 2019-06-30 13F INFUSYSTEM HLDGS COM 45685K102 1,880 1,827 3,447.17 8 -33.33 0.0000
2019-05-15 2019-03-31 13F INFUSYSTEM HLDGS COM 45685K102 53 -214 -80.15 0 -100.00
2019-02-14 2018-12-31 13F INFUSYSTEM HLDGS COM 45685K102 267 -4,242 -94.08 1 -93.33 0.0000
2019-04-23 2018-09-30 13F/A-2 INFUSYSTEM HLDGS COM 45685K102 4,509 315 7.51 15 0.00 0.0000
2018-11-20 2018-09-30 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 4,509 0 15 0.0000
2018-11-14 2018-09-30 13F INFUSYSTEM HLDGS COM 45685K102 4,509 315 15
2019-04-23 2018-06-30 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 4,194 4,194 -6.99 15 0.00 0.0000
2018-08-14 2018-06-30 13F INFUSYSTEM HLDGS COM 45685K102 4,194 4,194 15
2017-11-14 2017-09-30 13F INFUSYSTEM HLDGS COM 45685K102 0 -6 -100.00 0 -100.00 0.0000
2017-08-11 2017-06-30 13F INFUSYSTEM HLDGS COM 45685K102 6 6 0 0.0000
2016-11-10 2016-09-30 13F INFUSYSTEM HLDGS COM 45685K102 0 -400 -100.00 0 -100.00
2016-08-12 2016-06-30 13F INFUSYSTEM HLDGS COM 45685K102 400 0 0.00 1 0.00 0.0000
2016-05-12 2016-03-31 13F INFUSYSTEM HLDGS COM 45685K102 400 400 0.00 1 0.00 0.0000
2015-08-12 2015-06-30 13F INFUSYSTEM HLDGS COM 45685K102 0 -43 -100.00 0 -100.00 0.0000
2015-05-14 2015-03-31 13F INFUSYSTEM HLDGS COM 45685K102 43 -5,250 -99.19 0 -100.00
2015-02-13 2014-12-31 13F INFUSYSTEM HLDGS COM 45685K102 5,293 651 14.02 17 21.43 0.0000
2014-12-16 2014-09-30 13F/A-1 INFUSYSTEM HLDGS COM 45685K102 4,642 4,642 14 0.0000
2014-11-14 2014-09-30 13F INFUSYSTEM HLDGS COM 45685K102 4,642 14 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.